BiotechTube
Home/Prime Medicine/Andrew Anzalone
AA

Andrew Anzalone

Scientific Co-Founder

Prime Medicine

Therapeutic Areas

Rare Genetic DiseasesGenetic Medicine

Prime Medicine Pipeline

DrugIndicationPhase
PM359Chronic Granulomatous Disease (CGD)Phase 1/2
PM446Glycogen Storage Disease Type 1b (GSD1b)Phase 1/2
Undisclosed (Liver)Wilson DiseasePreclinical
Undisclosed (Eye)Retinitis Pigmentosa (CEP290-related)Preclinical

Leadership Team at Prime Medicine

AR
Allan Reine
Chief Executive Officer
MA
Mohammed Asmal
Chief Medical Officer
AL
Ann Lee
Chief Technical Officer
MH
Matthew Hawryluk
Chief Business Officer
RB
Ryan Brown
Chief Legal Officer
NA
Niamh Alix
Chief Human Resources Officer
DL
David Liu
Scientific Co-Founder
JM
Jeff Marrazzo
Executive Chair of the Board
View full Prime Medicine profile